v3.26.1
SCHEDULE OF INFORMATION RELATED TO OPERATIONS OF REPORTABLE OPERATING SEGMENTS (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]    
Share based compensation to employees and directors $ 91 $ 1
Change in fair value of warrant liability (234) 5
Depreciation (1)  
Total Operating loss (4,230) (3,283)
Other income 1,811 428
Net loss before tax (3,613) (4,319)
Income taxes (18)
Net loss (4,156) (5,347)
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Professional services (1,727) (1,791)
Share based compensation to employees and directors (2,386) (1,055)
Change in fair value of warrant liability 1,136  
Depreciation (1)
Other general and administrative expenses (586) (437)
Total Operating loss (4,230) (3,283)
Interest of loans (77)
Financing expenses, net (1,468) (252)
Other income 1,811 428
Changes in fair value of investments measured under the fair value option 351 (1,212)
Net loss before tax (3,613) (4,319)
Income taxes 18
Net loss (3,595) (4,319)
Operating Segments [Member] | Biotechnology Activity [Member]    
Segment Reporting Information [Line Items]    
Revenue from renewable energy projects
Cost related to renewable energy projects [1] (169)
Salaries and related expenses related to biotechnology activity (157)  
Operating loss from renewable energy projects (326)
Operating Segments [Member] | Renewable Energy Projects [Member]    
Segment Reporting Information [Line Items]    
Revenue from renewable energy projects
Cost related to renewable energy projects [2] (340)
Operating loss from renewable energy projects $ (340)
[1] Costs related to biotechnology activity primarily consist of subcontractors engaged in research and development activities.
[2] Costs related to renewable energy projects primarily consist of expenses incurred for subcontractors providing professional services.